Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

A cancer patient's hair became permanently curly after treatment with nivolumab.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Baricitinib successfully treated severe hair loss.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Dupilumab for skin problems might reactivate hair loss in some patients.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.